纤维化治疗的进展和挑战
Lilia Abbad1, Emmanuel Esteve1, Christos Chatziantoniou2
1INSERM UMR S 1155, Common and Rare Kidney Diseases, Tenon Hospital, Faculty of Medicine, Sorbonne University, Paris, France.
Nature reviews. Nephrology
|February 11, 2025
概括
慢性病 (CKD) 影响全球10%以上的成年人. 针对纤维化,细胞修复和药物输送的新治疗策略显示出治疗这种疾病的前景.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 纤维化研究 纤维化研究
- 翻译医学是一种翻译医学.
背景情况:
- 慢性病 (CKD) 是一个重要的全球健康问题,影响超过10%的成年人.
- 目前的CKD治疗方法,如透析和移植,并没有治愈,而且很昂贵.
- 纤维化,以细胞外矩阵积累为特征,是CKD进展和衰竭的主要驱动因素.
研究的目的:
- 审查CKD纤维化目前的理解和治疗方法.
- 探索现有治疗方法的局限性,特别是TGFβ抑制.
- 突出用于改善CKD治疗的新兴策略和技术.
主要方法:
- 对纤维化前临床和临床研究的文献综述.
- 分析转化生长因子-β (TGFβ) 在纤维化中信号传递的作用.
- 评估CKD当前和新型治疗干预措施.
主要成果:
- 抑制TGFβ信号传递,虽然在临床前模型中有效,但尚未成功转化为临床实践.
- 抗高血压和抗糖尿病药物可能会减缓纤维化,但它们的作用很难在体内评估.
- 针对亲纤维细胞通路,细胞重编程和先进的药物输送系统的新药类提供潜在的治疗益处.
结论:
- 尽管面临挑战,但正在出现新的治疗途径,用于治疗慢性病中的纤维化.
- 药物开发,患者分层和基于纳米技术的输送系统的进步对于未来的治疗至关重要.
- 解决纤维化仍然是改善慢性病结果的关键目标.
相关概念视频
01:45Kidney Structure
68.6K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.6K
01:09Introduction to Fibroblasts
3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
01:27Dialysis
254
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
254
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K